Cardioplegia 101

The Future:Therapy of Myocardial Protection

Recent studies have proposed that old, inexpensive drugs--in human use for decades (e.g., β-blockers and cyclosporine, among others)--can reduce ischemia/reperfusion injury, I/R injury, when administered intravenously before coronary opening. The demonstration of such a cardioprotective effect should have a significant impact in the care of AMI patients.

Single Dose Myocardial Protection Technique Utilizing del Nido Cardioplegia Solution During Congenital Heart Surgery Procedures

del Nido cardioplegia solution is a reasonable tool for myocardial protection during congenital heart surgery that significantly decreased the number of cardioplegic interventions and perioperative glucose values in our study groups.